# EDGAR Filing Document

**Accession Number:** 0001633336
**File Stem:** 0001193125-23-065845
**Filing Date:** 2023-3
**Character Count:** 15003
**Document Hash:** 403707ebc49e1bf9735b6b45d4533417
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-065845.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 0001193125-23-065845

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230309

**DATE AS OF CHANGE**: 20230309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Crescent Capital BDC, Inc.
- **CENTRAL INDEX KEY:** 0001633336
- **IRS NUMBER:** 473162282
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39207
- **FILM NUMBER:** 23719143

**BUSINESS ADDRESS:**
- **STREET 1:** 11100 SANTA MONICA BLVD.
- **STREET 2:** SUITE 2000
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90025
- **BUSINESS PHONE:** 310-235-5971

**MAIL ADDRESS:**
- **STREET 1:** 11100 SANTA MONICA BLVD.
- **STREET 2:** SUITE 2000
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90025

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 8-A** 

------

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES** 

**PURSUANT TO SECTION 12(b) OR (g) OF** 

**THE SECURITIES EXCHANGE ACT OF 1934** 

------

## Crescent Capital BDC, Inc.
**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Maryland** | **47-3162282** |
| **(State or incorporation or organization)** | **(I.R.S. Employer Identification Number)** |
| **11100 Santa Monica Blvd., Suite 2000,<br>Los Angeles, CA** | **90025** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Securities to be registered pursuant to Section 12(b) of the Act:** 

---

| | |
|:---|:---|
| **Title of each class**<br> **to be so registered** | **Name of each exchange on which**<br> **each class is to be registered** |
| **5.00% Notes due 2026** | **New York Stock Exchange** |

---

------

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

**Securities Act registration statement or Regulation A offering statement file number to which this form relates:** 

**333-238621** 

**Securities to be registered pursuant to Section 12(g) of the Act:** 

**None** 

------

**INFORMATION REQUIRED IN REGISTRATION STATEMENT** 

**Item 1.** **Description of Registrant's Securities to be Registered.** <br>

The description of the 5.00% Notes due 2026 (the "Notes") is incorporated herein by reference to the information set forth under the heading "Description of Our Debt Securities" in First Eagle Alternative Capital BDC, Inc.'s ("FCRD") Prospectus included in the Registration Statement on Form N-2 (Registration No. 333-238621), as filed with the Securities and Exchange Commission (the "SEC") on December 3, 2020 under the Securities Act of 1933, as amended (the "Securities Act"), and the information under the heading "Specific Terms of the Notes and the Offering" in each of FCRD's Prospectus Supplements dated May 18, 2021 and November 17, 2021, respectively, as filed with the SEC on May 19, 2021 and November 17, 2021, respectively, pursuant to Rule 424 under the Securities Act. The foregoing descriptions are incorporated herein by reference. The Notes are listed on the New York Stock Exchange under the trading symbol "FCRX."

On October 3, 2022, Crescent Capital BDC, Inc., a Maryland corporation ("CCAP") entered into an Agreement and Plan of Merger (the "Merger Agreement") with FCRD, Echelon Acquisition Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of CCAP ("Acquisition Sub"), Echelon Acquisition Sub LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of CCAP ("Acquisition Sub 2"), and Crescent Cap Advisors, LLC, a Delaware limited liability company and the external investment adviser to CCAP. The Merger Agreement provides that (i) Acquisition Sub will merge with and into FCRD (the "First Merger"), with FCRD continuing as the surviving corporation, and (ii) immediately after the effectiveness of the First Merger, FCRD will merge with and into Acquisition Sub 2 (the "Second Merger"), with Acquisition Sub 2 continuing as the surviving company (the "Surviving Company").

On March 9, 2023, CCAP and the Surviving Company entered into an Agreement and Plan of Merger (the "Third Merger Agreement"). The Third Merger Agreement provides that the Surviving Company will merge with and into CCAP (the "Third Merger"), with CCAP continuing as the surviving entity.

Following consummation of the Third Merger, CCAP will assume the outstanding Notes of FCRD and the indenture relating to such Notes.

**Item 2.** **Exhibits.** <br>

Pursuant to the Instructions as to exhibits for registration statements on Form 8-A, the documents listed below are filed as exhibits to this Registration Statement:

---

| | |
|:---|:---|
| **Number** | **Exhibit** |
| 4.1 | Form of Indenture and related exhibits between FCRD and U.S. Bank National Association, as trustee (incorporated herein by reference to Exhibit d.2 filed with Pre-Effective Amendment No. 1 to FCRD's Registration Statement on Form N-2 (File No. 333-175074) filed on August 25, 2011). |
| 4.2 | Fourth Supplemental Indenture, relating to the 5.00% Notes due 2026, between FCRD and U.S. Bank National Association, as trustee (incorporated herein by reference to Exhibit 4.1 filed with FCRD's Current Report on Form 8-K filed on May 25, 2021). |
| 4.3 | Form of 5.00% Note due 2026 (incorporated herein by reference to Exhibit 4.1 filed with FCRD's Current Report on Form 8-K filed on May 25, 2021). |
| 4.4 | Fifth Supplemental Indenture between CCAP and U.S. Bank National Association, as trustee (filed herewith). |

---

------

**SIGNATURE** 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| Crescent Capital BDC, Inc. | Crescent Capital BDC, Inc. |
| By: | /s/ Gerhard Lombard |
|  | Name: Gerhard Lombard |
|  | Title: Chief Financial Officer |

---

Date: March 9, 2023

## Exhibit 4.4

**Exhibit 4.4** 

FIFTH SUPPLEMENTAL INDENTURE

Fifth Supplemental Indenture (this "<u>Supplemental Indenture</u>"), dated as of March 9, 2023, by and between Crescent Capital BDC, Inc., a Maryland corporation ("<u>CCAP</u>") (as successor to Acquisition Sub 2 (as defined below), successor to First Eagle Alternative Capital BDC, Inc., a Delaware corporation ("<u>FCRD</u>")), and U.S. Bank National Association, as trustee (the "<u>Trustee</u>").

W I T N E S S E T H

WHEREAS, on October 3, 2022, FCRD, CCAP, Echelon Acquisition Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of CCAP ("<u>Acquisition Sub</u>"), Echelon Acquisition Sub LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of CCAP ("<u>Acquisition Sub 2</u>"), and Crescent Cap Advisors, LLC, a Delaware limited liability company and the external investment adviser to CCAP, entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified to date, the "<u>Merger Agreement</u>"), pursuant to which, on the date hereof, (i) Acquisition Sub merged with and into FCRD, with FCRD continuing as the surviving corporation (the "<u>First Surviving Corporation</u>"), and (ii) the First Surviving Corporation merged with and into Acquisition Sub 2 (such merger, the "<u>Second Merger</u>"), with Acquisition Sub 2 continuing as the surviving entity (the "<u>Surviving Company</u>");

WHEREAS, on the date hereof, CCAP and the Surviving Company entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified to date, the "<u>Third Merger Agreement</u>"), pursuant to which, on the date hereof, immediately following the Second Merger, the Surviving Company merged with and into CCAP, with CCAP continuing as the surviving entity;

WHEREAS, FCRD has heretofore executed and delivered to the Trustee the indenture, dated as of November 18, 2014 (the "<u>Base Indenture</u>"), by and between FCRD and the Trustee, as amended and supplemented by the fourth supplemental indenture thereto, dated as of May 25, 2021 (the "<u>Fourth Supplemental Indenture</u>") (the Base Indenture, as amended and supplemented by the Fourth Supplemental Indenture, the "<u>Original Indenture</u>");

WHEREAS, the Fourth Supplemental Indenture establishes the form and terms of FCRD's 5.00% Notes due 2026 (the "<u>Notes</u>") and provides for the issuance of the Notes;

WHEREAS, FCRD previously entered into the first supplemental indenture, dated as of November 18, 2014 (the "<u>First Supplemental Indenture</u>"), the second supplemental indenture, dated as of December 14, 2015 (the "<u>Second Supplemental Indenture</u>"), and the third supplemental indenture, dated as of October 5, 2018 (the "<u>Third Supplemental Indenture</u>"), each of which supplemented and amended the Base Indenture, and none of the First Supplemental Indenture, the Second Supplemental Indenture or the Third Supplemental Indenture is applicable to the Notes;

WHEREAS, Section 8.01 of the Original Indenture provides that any successor entity to FCRD shall expressly assume all of the obligations of FCRD under the Original Indenture; and

WHEREAS, pursuant to Section 9.01 of the Original Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture (Original Indenture, as amended and supplemented by this Supplemental Indenture, the "<u>Indenture</u>").

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Capitalized Terms</u>. Capitalized terms used herein without definition shall have the meanings assigned to them in the Original Indenture.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Assumption of Obligations</u>. CCAP (as successor to Acquisition Sub 2, successor to FCRD), hereby expressly assumes all the obligations of FCRD under the Original Indenture and the Notes, including the due and punctual payment of the principal of (and premium, if any) and interest, if any, on all the Notes and the performance of every covenant of the Original Indenture on the part of the FCRD to be performed or observed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. This Supplemental Indenture and the Notes shall be governed by and construed in accordance with the law of the State of New York, without regard to principles of conflicts of laws. This Supplemental Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent applicable, be governed by such provisions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. In case any provision in this Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. This Supplemental Indenture may be executed in counterparts, each of which will be an original, but such counterparts will together constitute but one and the same Supplemental Indenture. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile, .pdf transmission, email or other electronic means shall constitute effective execution and delivery of this Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile, .pdf transmission, email or other electronic means shall be deemed to be their original signatures for all purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The provisions of this Supplemental Indenture shall become effective as of the date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The recitals contained herein shall be taken as the statements of CCAP, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Supplemental Indenture or the Notes, except that the Trustee represents that it is duly authorized to execute and deliver this Supplemental Indenture and authenticate the Notes and perform its obligations hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Waiver of Jury Trial.</u> EACH OF CCAP AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Headings</u>. The headings of the Sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof.

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.

---

| | |
|:---|:---|
|  CRESCENT CAPITAL BDC, INC. | CRESCENT CAPITAL BDC, INC. |
|  By: | /s/ Gerhard Lombard |
|  | Name: Gerhard Lombard |
|  | Title: Chief Financial Officer |

---

[*Signature Page to Supplemental Indenture*]

------

---

| | |
|:---|:---|
|  U.S. BANK NATIONAL ASSOCIATION,<br> as Trustee | U.S. BANK NATIONAL ASSOCIATION,<br> as Trustee |
|  By: | /s/ Donald Higgins |
|  | Name: Donald Higgins |
|  | Title: Vice President |

---

[*Signature Page to Supplemental Indenture*]